Filing Details
- Accession Number:
- 0001104659-20-088216
- Form Type:
- 13D Filing
- Publication Date:
- 2020-07-30 11:12:36
- Filed By:
- Bpifrance Participations Sa
- Company:
- Tempest Therapeutics Inc. (NASDAQ:TPST)
- Filing Date:
- 2020-07-30
- SEC Url:
- 13D Filing
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
---|---|---|---|---|---|---|
Fonds Innobio FPCI | 0 | 590,105 | 0 | 590,105 | 590,105 | 3.1% |
Bpifrance Investissement S.A.S | 0 | 590,105 | 0 | 590,105 | 590,105 | 3.1% |
Bpifrance Participations S.A | 0 | 590,105 | 0 | 590,105 | 590,105 | 3.1% |
Caisse des D p ts | 0 | 590,105 | 0 | 590,105 | 590,105 | 3.1% |
EPIC Bpifrance | 0 | 590,105 | 0 | 590,105 | 590,105 | 3.1% |
Bpifrance S.A | 0 | 590,105 | 0 | 590,105 | 590,105 | 3.1% |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
Millendo Therapeutics, Inc.
(Name of Issuer)
Common Stock, par value $0.001 per share
(Title of Class of Securities)
60040X103
(CUSIP Number)
Sophie Paquin
Bpifrance Participations S.A.
6-8, boulevard Haussmann
75009 Paris
France
+33 1 53 89 55 73
With copy to:
John C. Partigan
Nixon Peabody LLP
799 9th Street NW, Suite 500
Washington, DC 20001
(202) 585-8000
((Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
July 23, 2020
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box o.
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.
CUSIP No. 60040X103 | |||||
| 1 | Name of Reporting Person | |||
| |||||
| 2 | Check the Appropriate Box if a Member of a Group (See Instructions) | |||
|
| (a) | o | ||
|
| (b) | o | ||
| |||||
| 3 | SEC Use Only | |||
|
|
| |||
| 4 | Source of Funds | |||
|
|
| |||
| 5 | Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o | |||
|
|
| |||
| 6 | Citizenship or Place of Organization | |||
|
|
| |||
Number of | 7 | Sole Voting Power | |||
| |||||
8 | Shared Voting Power | ||||
| |||||
9 | Sole Dispositive Power | ||||
| |||||
10 | Shared Dispositive Power | ||||
| |||||
| 11 | Aggregate Amount Beneficially Owned by Each Reporting Person | |||
| |||||
| 12 | Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o | |||
| |||||
| 13 | Percent of Class Represented by Amount in Row (11) | |||
| |||||
| 14 | Type of Reporting Person (See Instructions) | |||
2
CUSIP No. 60040X103 | |||||
| 1 | Name of Reporting Person | |||
| |||||
| 2 | Check the Appropriate Box if a Member of a Group (See Instructions) | |||
|
| (a) | o | ||
|
| (b) | o | ||
| |||||
| 3 | SEC Use Only | |||
|
|
| |||
| 4 | Source of Funds | |||
|
|
| |||
| 5 | Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o | |||
|
|
| |||
| 6 | Citizenship or Place of Organization | |||
|
|
| |||
Number of | 7 | Sole Voting Power | |||
| |||||
8 | Shared Voting Power | ||||
| |||||
9 | Sole Dispositive Power | ||||
| |||||
10 | Shared Dispositive Power | ||||
| |||||
| 11 | Aggregate Amount Beneficially Owned by Each Reporting Person | |||
| |||||
| 12 | Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o | |||
| |||||
| 13 | Percent of Class Represented by Amount in Row (11) | |||
| |||||
| 14 | Type of Reporting Person (See Instructions) | |||
3
CUSIP No. 60040X103 | |||||
| 1 | Name of Reporting Person | |||
| |||||
| 2 | Check the Appropriate Box if a Member of a Group (See Instructions) | |||
|
| (a) | o | ||
|
| (b) | o | ||
| |||||
| 3 | SEC Use Only | |||
|
|
| |||
| 4 | Source of Funds | |||
|
|
| |||
| 5 | Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o | |||
|
|
| |||
| 6 | Citizenship or Place of Organization | |||
|
|
| |||
Number of | 7 | Sole Voting Power | |||
| |||||
8 | Shared Voting Power | ||||
| |||||
9 | Sole Dispositive Power | ||||
| |||||
10 | Shared Dispositive Power | ||||
| |||||
| 11 | Aggregate Amount Beneficially Owned by Each Reporting Person | |||
| |||||
| 12 | Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o | |||
| |||||
| 13 | Percent of Class Represented by Amount in Row (11) | |||
| |||||
| 14 | Type of Reporting Person (See Instructions) | |||
4
CUSIP No. 60040X103 | |||||
| 1 | Name of Reporting Person | |||
| |||||
| 2 | Check the Appropriate Box if a Member of a Group (See Instructions) | |||
|
| (a) | o | ||
|
| (b) | o | ||
| |||||
| 3 | SEC Use Only | |||
|
|
| |||
| 4 | Source of Funds | |||
|
|
| |||
| 5 | Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o | |||
|
|
| |||
| 6 | Citizenship or Place of Organization | |||
|
|
| |||
Number of | 7 | Sole Voting Power | |||
| |||||
8 | Shared Voting Power | ||||
| |||||
9 | Sole Dispositive Power | ||||
| |||||
10 | Shared Dispositive Power | ||||
| |||||
| 11 | Aggregate Amount Beneficially Owned by Each Reporting Person | |||
| |||||
| 12 | Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o | |||
| |||||
| 13 | Percent of Class Represented by Amount in Row (11) | |||
| |||||
| 14 | Type of Reporting Person (See Instructions) | |||
5
CUSIP No. 60040X103 | |||||
| 1 | Name of Reporting Person | |||
| |||||
| 2 | Check the Appropriate Box if a Member of a Group (See Instructions) | |||
|
| (a) | o | ||
|
| (b) | o | ||
| |||||
| 3 | SEC Use Only | |||
|
|
| |||
| 4 | Source of Funds | |||
|
|
| |||
| 5 | Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o | |||
|
|
| |||
| 6 | Citizenship or Place of Organization | |||
|
|
| |||
Number of | 7 | Sole Voting Power | |||
| |||||
8 | Shared Voting Power | ||||
| |||||
9 | Sole Dispositive Power | ||||
| |||||
10 | Shared Dispositive Power | ||||
| |||||
| 11 | Aggregate Amount Beneficially Owned by Each Reporting Person | |||
| |||||
| 12 | Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o | |||
| |||||
| 13 | Percent of Class Represented by Amount in Row (11) | |||
| |||||
| 14 | Type of Reporting Person (See Instructions) | |||
6
CUSIP No. 60040X103 | |||||
| 1 | Name of Reporting Person | |||
| |||||
| 2 | Check the Appropriate Box if a Member of a Group (See Instructions) | |||
|
| (a) | o | ||
|
| (b) | o | ||
| |||||
| 3 | SEC Use Only | |||
|
|
| |||
| 4 | Source of Funds | |||
|
|
| |||
| 5 | Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) o | |||
|
|
| |||
| 6 | Citizenship or Place of Organization | |||
|
|
| |||
Number of | 7 | Sole Voting Power | |||
| |||||
8 | Shared Voting Power | ||||
| |||||
9 | Sole Dispositive Power | ||||
| |||||
10 | Shared Dispositive Power | ||||
| |||||
| 11 | Aggregate Amount Beneficially Owned by Each Reporting Person | |||
| |||||
| 12 | Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) o | |||
| |||||
| 13 | Percent of Class Represented by Amount in Row (11) | |||
| |||||
| 14 | Type of Reporting Person (See Instructions) | |||
7
Amendment No. 2 to Schedule 13D
This Amendment No. 2 (this Amendment) is filed jointly by (i) Fonds Innobio FPCI (Innobio), a fonds professionnel de capital investissement, (ii) Bpifrance Investissement S.A.S., a French management company (société de gestion) (Bpifrance Investissement), (iii) Bpifrance Participations S.A., a société anonyme incorporated under the laws of the Republic of France (Bpifrance Participations), (iv) the Caisse des Dépôts, a French special public entity (établissement spécial) (CDC), (v) EPIC Bpifrance, a French public institution of industrial and commercial nature (EPIC), and (vi) Bpifrance S.A. (Bpifrance), a société anonyme incorporated under the laws of the Republic of France (collectively, the Reporting Persons).
This Amendment further amends (i) the Schedule 13D filed on December 13, 2018 and (ii) the Amendment No. 1 to Schedule 13D filed on December 16, 2019 (collectively, the Schedule 13D).
Capitalized terms used herein but not otherwise defined herein shall have the respective meanings ascribed thereto in the Schedule 13D, as amended hereby.
Item 2. Identity and Background.
The penultimate paragraph in Item 4 is hereby amended and replaced as follows:
Attached as Appendices A, B, C, D and E to Item 2 is information concerning the executive officers and directors of Bpifrance Investissement, Bpifrance Participations, CDC, EPIC and Bpifrance, respectively, required to be disclosed in response to Item 2 and General Instruction C to Schedule 13D. Innobio is formed under the laws of the Republic of France as a fonds professionnel de capital investissement. Innobio does not have legal capacity under French law or its own personnel, and is represented in all respects by Bpifrance Investissement, its manager.
Item 4. Purpose of Transaction.
Item 4 is hereby amended and supplemented as follows:
Innobio sold an aggregate of 488,565 Common Shares in the open market as follows: (i) 6,200 Common Shares on July 21, 2020; (ii) 50,000 Common Shares on July 22, 2020; and (iii) 432,365 Common Shares on July 23, 2020. This Amendment is being filed to report the fact that as of July 23, 2020, the Reporting Persons has ceased to be the beneficial owner of more than 5 percent of the Issuers Common Shares.
Ownership is stated as of July 23, 2020 and the ownership percentages are based on 18,999,701 shares of common stock, $0.001 par value per share (Common Shares), outstanding as of May 5, 2020, as disclosed by Millendo Therapeutics, Inc. in its Form 10-Q for the quarterly period ended March 31, 2020, filed on May 8, 2020.
All of the Common Shares that are held of record by the Reporting Persons as reported herein were acquired for investment purposes. The Reporting Persons retain the right to change their investment intent, from time to time to acquire additional Common Shares or other securities of the Issuer, or to sell or otherwise dispose of all or part of the Common Shares or other securities of the Issuer, if any, beneficially owned by them, in any manner permitted by law. The Reporting Persons may engage from time to time in ordinary course transactions with financial institutions with respect to the securities described herein.
Except as set forth above, none of the Reporting Persons currently has any plans or proposals which would be related to or would result in any of the matters described in Items 4(a)-(j) of the Instructions to Schedule 13D. However, as part of the ongoing evaluation of investment and investment alternatives, the Reporting Persons may consider such matters and, subject to applicable law, may formulate a plan with respect to such matters, and, from time to time, may hold discussions with or make formal proposals to management or the board of directors of the Issuer or other third parties regarding such matters.
Item 5. Interest in Securities of the Issuer.
Please see Items 5, 6, 7, 8, 9 and 11 of each cover sheet for each filing entity.
8
As of July 23, 2020, Innobio held directly 590,105 Common Stock. None of Bpifrance, CDC, EPIC, Bpifrance Participations nor Bpifrance Investissement held any Common Stock directly. Bpifrance Investissement may be deemed to be the beneficial owner of the 590,105 Common Stock held by Innobio, through its management of Innobio. Bpifrance Participations may be deemed to be the beneficial owner of 590,105 Common Stock, indirectly through its sole ownership of Bpifrance Investissement. Bpifrance may be deemed to be the beneficial owner of 590,105 Common Stock, indirectly through its sole ownership of Bpifrance Participations, which is the parent company of Bpifrance Investissement. EPIC may be deemed to be the beneficial owner of 590,105 Common Stock, indirectly through its joint ownership and control of Bpifrance. CDC may be deemed to be the beneficial owner of 590,105 Common Stock indirectly through its joint ownership and control of Bpifrance.
(a) See also the information contained on the cover pages of this Amendment, which is incorporated herein by reference. The percentage of Common Shares beneficially owned by each Reporting Person is based on 18,999,701 Common Shares of the Issuer outstanding as of May 5, 2020.
(b) See the information contained on the cover pages of this Schedule 13D, which is incorporated herein by reference.
(c) There have been no reportable transactions with respect to the Common Shares of the Issuer within the last 60 days by the Reporting Persons other than as described in this Amendment No. 2.
(d) Not applicable.
(e) Not applicable.
9
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: July 30, 2020 |
| Fonds Innobio FPCI | |
|
|
| |
|
|
| |
|
| By: | /s/ Laurent Arthaud* |
|
| Name: | Laurent Arthaud |
|
| Title: | Associate Director in Charge of Funds (Bpifrance Investissement S.A.S.) |
|
|
| |
|
|
| |
|
| Bpifrance Investissement S.A.S. | |
|
|
| |
|
|
| |
|
| By: | /s/ Boubakar Dione** |
|
| Name: | Boubakar Dione |
|
| Title: | Group Director of Legal Affairs |
|
|
| |
|
|
| |
|
| Bpifrance Participations S.A. | |
|
|
| |
|
|
| |
|
| By: | /s/ Boubakar Dione*** |
|
| Name: | Boubakar Dione |
|
| Title: | Group Director of Legal Affairs |
|
|
| |
|
|
| |
|
| Caisse des Dépôts | |
|
|
| |
|
|
| |
|
| By: | /s/ Eric Flamarion**** |
|
| Name: | Eric Flamarion |
|
| Title: | Head of Financial Investment Division |
|
|
| |
|
|
| |
|
| EPIC Bpifrance | |
|
|
| |
|
|
| |
|
| By: | /s/ Boubakar Dione***** |
|
| Name: | Boubakar Dione |
|
| Title: | Group Director of Legal Affairs |
|
|
| |
|
|
| |
|
| Bpifrance S.A. | |
|
|
| |
|
|
| |
|
| By: | /s/ Boubakar Dione****** |
|
| Name: | Boubakar Dione |
|
| Title: | Group Director of Legal Affairs |
10
* Laurent Arthaud is signing on behalf of Fonds Innobio FPCI, by power of attorney from Bpifrance Investissement S.A.S. filed with the Securities and Exchange Commission on October 15, 2019 as Exhibit 99.5 to Schedule 13D filed by Bpifrance Participations S.A. related to DBV Technologies S.A., and hereby incorporated herein by reference.
** Boubakar Dione is signing on behalf of Bpifrance Investissement S.A.S. by power of attorney filed with the Securities and Exchange Commission on October 15, 2019 as Exhibit 99.3 to Schedule 13D filed by Bpifrance Participations S.A. related to DBV Technologies S.A., and hereby incorporated herein by reference.
*** Boubakar Dione is signing on behalf of Bpifrance Participations S.A. by power of attorney filed with the Securities and Exchange Commission on October 15, 2019 as Exhibit 99.2 to Schedule 13D filed by Bpifrance Participations S.A. related to DBV Technologies S.A., and hereby incorporated herein by reference.
**** Eric Flamarion is signing on behalf of Caisse des Dépôts by executive order from the general manager of Caisse des Dépôts previously filed with the Securities and Exchange Commission on April 12, 2018 as Exhibit 99.2 to Schedule 13D filed by Bpifrance Participations related to DBV Technologies S.A., and hereby incorporated herein by reference.
***** Boubakar Dione is signing on behalf of EPIC Bpifrance by power of attorney filed with the Securities and Exchange Commission on October 15, 2019 as Exhibit 99.4 to Schedule 13D filed by Bpifrance Participations S.A. related to DBV Technologies S.A., and hereby incorporated herein by reference.
****** Boubakar Dione is signing on behalf of Bpifrance S.A. by power of attorney previously filed with the Securities and Exchange Commission on September 7, 2017 as Exhibit 2 to Schedule 13D/A filed by Bpifrance Participations related to Constellium N.V., and hereby incorporated herein by reference.
11
APPENDIX A
Name, business address, present principal occupation or employment and place of citizenship of the directors and executive officers of
BPIFRANCE INVESTISSEMENT
The name, business address and present principal occupation or employment of each of the directors and executive officers of Bpifrance Investissement are set forth below. The business address of each director and executive officer is Bpifrance Investissement S.A.S., 27-31, avenue du Général Leclerc, 94710 Maisons-Alfort Cedex, France. Unless otherwise indicated, each director and executive officer is a citizen of France.
BOARD OF DIRECTORS
Name |
| Present Principal Occupation or Employment |
|
|
|
NICOLAS DUFOURCQ |
| Director, Chairman, Chief Executive Officer of Bpifrance Participations, and Chief Executive Officer of Bpifrance |
|
|
|
VIRGINIE FERNANDES |
| Director, Head of the Steering Department at Caisse des Dépôts |
|
|
|
CATHERINE MAYENOBE |
| Director, Secretary General of the Caisse des Dépôts |
|
|
|
FREDERIC SAINT-GEOURS |
| Director, President of the supervisory board of SNCF |
|
|
|
FRENCH STATE, represented by CHARLES SARRAZIN |
| Director, in charge of shareholding interests in the Service & Finance sectors, Agence des Participations de lEtat (French State Shareholding Agency) |
|
|
|
CONSTANCE VALIGNY |
| Director, Assistant Director for macroeconomic policies, Direction Générale du Trésor (French Treasury) |
|
|
|
BARBARA LAVERNOS |
| Director, Executive Vice-President Operations at LOreal |
|
|
|
VICTOIRE AUBRY |
| Director, Chief Financial Officer of Icade |
|
|
|
SOPHIE STABILE |
| Founder and CEO of Révérence |
|
|
|
JULIEN TOGNOLA |
| Chief, Service of Industry, General Directorate for Companies of the Ministry of Economy and Finance |
EXECUTIVE OFFICERS
Name |
| Present Principal Occupation or Employment |
|
|
|
NICOLAS DUFOURCQ |
| Chief Executive Officer |
|
|
|
JOSÉ GONZALO |
| Executive Director |
|
|
|
PIERRE BENEDETTI |
| Chief Financial Officer |
1
APPENDIX B
Name, business address, present principal occupation or employment and place of citizenship of the directors and executive officers of
BPIFRANCE PARTICIPATIONS S.A.
The name, business address and present principal occupation or employment of each of the directors and executive officers of Bpifrance Participations S.A. are set forth below. The business address of each director and executive officer is Bpifrance Participations S.A., 27-31, avenue du Général Leclerc, 94710 Maisons-Alfort Cedex, France. Unless otherwise indicated, each director and executive officer is a citizen of France.
BOARD OF DIRECTORS
Name |
| Present Principal Occupation or Employment |
|
|
|
NICOLAS DUFOURCQ |
| Director, Chairman, Chief Executive Officer of Bpifrance Participations, and Chief Executive Officer of Bpifrance |
|
|
|
VIRGINIE FERNANDES |
| Director, Head of the Steering Department at Caisse des Dépôts |
|
|
|
CATHERINE MAYENOBE |
| Director, Secretary General of the Caisse des Dépôts Group |
|
|
|
FREDERIC SAINT-GEOURS |
| Director, President of the supervisory board of SNCF |
|
|
|
FRENCH STATE, represented by CHARLES SARRAZIN |
| Director, in charge of shareholding interests in the Service & Finance sectors, Agence des Participations de lEtat (French State Shareholding Agency) |
|
|
|
CONSTANCE VALIGNY |
| Director, Assistant Director for macroeconomic policies, Direction Générale du Trésor (French Treasury) |
|
|
|
BARBARA LAVERNOS |
| Director, Executive Vice-President Operations at LOreal |
|
|
|
VICTOIRE AUBRY |
| Director, Chief Financial Officer of Icade |
|
|
|
SOPHIE STABILE |
| Founder and CEO of Révérence |
|
|
|
JULIEN TOGNOLA |
| Chief, Service of Industry, General Directorate for Companies of the Ministry of Economy and Finance |
EXECUTIVE OFFICERS
Name |
| Present Principal Occupation or Employment |
|
|
|
NICOLAS DUFOURCQ |
| Chief Executive Officer |
|
|
|
JOSÉ GONZALO |
| Executive Director |
|
|
|
PIERRE BENEDETTI |
| Chief Financial Officer |
2
APPENDIX C
Name, business address, present principal occupation or employment and place of citizenship of the directors and executive officers of
CAISSE DES DÉPÔTS
The name, business address and present principal occupation or employment of each of the members of the Management Committee of Caisse des Dépôts are set forth below. The business address of each director and executive officer is Caisse des Dépôts, c/o 56, rue de Lille, 75007 Paris, France. Unless otherwise indicated, each such person is a citizen of France.
MANAGEMENT COMMITTEE
Name |
| Present Principal Occupation or Employment |
|
|
|
ERIC LOMBARD |
| Chief Executive Officer of Caisse des Dépôts |
|
|
|
OLIVIER SICHEL |
| Deputy Chief Executive Officer of Caisse des Dépôts |
|
|
|
NICOLAS DUFOURCQ |
| Chief Executive Officer of Bpifrance |
|
|
|
VIRGINIE CHAPRON-DU-JEU |
| Director of Finance for the Caisse des Dépôts Group |
|
|
|
PIERRE CHEVALIER |
| Head of Legal and Tax Department |
|
|
|
NATHALIE TUBIANA |
| Risk Director of the Caisse des Dépôts Group |
|
|
|
OLIVIER MAREUSE |
| Chief Investment officer - Director of Savings Funds at Caisse des Dépôts |
|
|
|
CATHERINE MAYENOBE |
| Secretary General of Caisse des Dépôts Group |
|
|
|
PAUL PENY |
| Caisse des Dépôts Group Human Resources Director |
|
|
|
SOPHIE QUATREHOMME |
| Group Corporate Communications Director |
|
|
|
MICHEL YAHIEL |
| Pensions and Solidarity Director |
3
APPENDIX D
Name, business address, present principal occupation or employment and place of citizenship of the directors and executive officers of
EPIC BPIFRANCE
The name, business address and present principal occupation or employment of each of the directors and executive officers of EPIC Bpifrance are set forth below. The business address of each director and executive officer is EPIC Bpifrance, 27-31, avenue du Général Leclerc, 94710 Maisons-Alfort Cedex, France. Unless otherwise indicated, each director and executive officer is a citizen of France.
DIRECTORS
Name |
| Present Principal Occupation or Employment |
|
|
|
CHRISTIAN BODIN |
| Chairman, Chief Executive Officer of EPIC Bpifrance |
|
|
|
PIERRE-LOUIS AUTIN |
| Director, Head of department SITTAR at the Higher Education, Research and Innovation Ministry |
|
|
|
YANN POUËZAT |
| Director, Deputy Director at the Directorate of Financing, Industry and Market of the Ministry of Economy and Finance |
|
|
|
ALBAN HAUTIER |
| Director, Deputy Director at the General Directorate for Budget of the Ministry of Economy and Finance |
|
|
|
SONIA BEURIER |
| Director |
|
|
|
MARIE ANNE LAVERGNE |
| Director |
|
|
|
NAOMI PERES |
| Director |
4
APPENDIX E
Name, business address, present principal occupation or employment and place of citizenship of the directors and executive officers of
BPIFRANCE S.A.
The name, business address and present principal occupation or employment of each of the directors and executive officers of Bpifrance S.A. are set forth below. The business address of each director and executive officer is Bpifrance S.A., 27-31, avenue du Général Leclerc, 94710 Maisons-Alfort Cedex, France. Unless otherwise indicated, each director and executive officer is a citizen of France.
DIRECTORS
Name |
| Present Principal Occupation or Employment |
|
|
|
ERIC LOMBARD |
| Chairman, Chief Executive Officer of the Caisse des Dépôts |
|
|
|
NICOLAS DUFOURCQ |
| Director, Chief Executive Officer of Bpifrance and Director, Chairman and Chief Executive Officer of Bpifrance Participations |
|
|
|
GUILLAUME BOUDY |
| Director, General Secretary for Public Investment |
|
|
|
MARTIN VIAL |
| Director, Chairman of the Agence des Participations de lEtat (French State Shareholding Agency) |
|
|
|
MARIE DELEAGE |
| Director representing the employees of Bpifrance |
|
|
|
PHILIPPE BAYEUX |
| Director representing the employees of Bpifrance |
|
|
|
VIRGINIE CHAPRON-DU JEU |
| Director, Group Finance Director of the Caisse des Dépôts |
|
|
|
CLAIRE DUMAS |
| Director, Finance Director of Retail Banking France at Société Générale |
|
|
|
CLAIRE CHEREMETINSKI |
| Director, Head of Department of Bilateral and International Matters at the French Treasury (Ministry of Economy and Finance) |
|
|
|
OLIVIER SICHEL |
| Director, Deputy Chief Executive Officer of the Caisse des Dépôts |
|
|
|
BERNARD DELPIT |
| Director, Chief Financial Officer of Safran |
|
|
|
ANNABEL ANDRE LAURENT |
| Director |
|
|
|
HAROLD HUWART |
| Director |
|
|
|
CAROLE ABBEY DUVAL |
| Director |
|
|
|
BARBARA LAVERNOS DUPUIS |
| Director |
|
|
|
DIANE SIMIU |
| Director |
5